255 related articles for article (PubMed ID: 6359378)
21. Pneumococcal vaccines: World Health Organization position paper.
Can Commun Dis Rep; 1999 Sep; 25(17):150-1. PubMed ID: 10513118
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of pneumococcal vaccination against recurrent otitis media. Preliminary results of a field trial in Finland.
Karma P; Luotonen J; Timonen M; Pöntynen S; Pukander J; Herva E; Grönroos P; Leinonen M; Sibakov M; Mäkelä PH
Ann Otol Rhinol Laryngol Suppl; 1980; 89(3 Pt 2):357-62. PubMed ID: 6778346
[TBL] [Abstract][Full Text] [Related]
23. Childhood vaccination against pneumococcal otitis media and pneumonia: an analysis of benefits and costs.
Weycker D; Richardson E; Oster G
Am J Manag Care; 2000 Jul; 6(10 Suppl):S526-35. PubMed ID: 11183904
[TBL] [Abstract][Full Text] [Related]
24. Otitis media. A scholarly review of the evidence.
Pappas DE; Owen Hendley J
Minerva Pediatr; 2003 Oct; 55(5):407-14. PubMed ID: 14608264
[TBL] [Abstract][Full Text] [Related]
25. Complicated otitis media and its implications.
Leibovitz E
Vaccine; 2008 Dec; 26 Suppl 7():G16-9. PubMed ID: 19094932
[TBL] [Abstract][Full Text] [Related]
26. Effect of pneumococcal conjugate vaccine on nasopharyngeal bacterial colonization during acute otitis media.
Revai K; McCormick DP; Patel J; Grady JJ; Saeed K; Chonmaitree T
Pediatrics; 2006 May; 117(5):1823-9. PubMed ID: 16651345
[TBL] [Abstract][Full Text] [Related]
27. Nasopharyngeal pneumococcal carriage after combined pneumococcal conjugate and polysaccharide vaccination in children with a history of recurrent acute otitis media.
Veenhoven RH; Bogaert D; Schilder AG; Rijkers GT; Uiterwaal CS; Kiezebrink HH; van Kempen MJ; Dhooge IJ; Bruin J; Ijzerman EP; de Groot R; Kuis W; Hermans PW; Sanders EA
Clin Infect Dis; 2004 Oct; 39(7):911-9. PubMed ID: 15472839
[TBL] [Abstract][Full Text] [Related]
28. Assessing vaccine efficacy for the prevention of acute otitis media by pneumococcal vaccination in children: a methodological overview of statistical practice in randomized controlled clinical trials.
Jahn-Eimermacher A; du Prel JB; Schmitt HJ
Vaccine; 2007 Aug; 25(33):6237-44. PubMed ID: 17629378
[TBL] [Abstract][Full Text] [Related]
29. The impact of pneumococcal conjugate vaccines on otitis media-can we extrapolate to pneumonia?
Dagan R
Vaccine; 2008 Jun; 26 Suppl 2():B16-8. PubMed ID: 18793601
[TBL] [Abstract][Full Text] [Related]
30. Immunisation with a pneumococcal 7-valent conjugate vaccine.
Dagan R
Int J Clin Pract; 2002 May; 56(4):287-91. PubMed ID: 12074212
[TBL] [Abstract][Full Text] [Related]
31. Pneumococcal conjugate vaccine serotypes of Streptococcus pneumoniae isolates and the antimicrobial susceptibility of such isolates in children with otitis media.
Joloba ML; Windau A; Bajaksouzian S; Appelbaum PC; Hausdorff WP; Jacobs MR
Clin Infect Dis; 2001 Nov; 33(9):1489-94. PubMed ID: 11588694
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of pneumococcal conjugate vaccine against PCR-positive acute otitis media.
Palmu AA; Saukkoriipi A; Jokinen J; Leinonen M; Kilpi TM
Vaccine; 2009 Mar; 27(10):1490-1. PubMed ID: 19168111
[TBL] [Abstract][Full Text] [Related]
33. Impact of pneumococcal conjugate vaccine and of reduction of antibiotic use on nasopharyngeal carriage of nonsusceptible pneumococci in children with acute otitis media.
Cohen R; Levy C; de La Rocque F; Gelbert N; Wollner A; Fritzell B; Bonnet E; Tetelboum R; Varon E
Pediatr Infect Dis J; 2006 Nov; 25(11):1001-7. PubMed ID: 17072121
[TBL] [Abstract][Full Text] [Related]
34. Pneumococcal vaccine and otitis media.
Mäkelä PH; Sibakov M; Herva E; Henrichsen J; Luotonen J; Timonen M; Leinonen M; Koskela M; Pukander J; Pöntynen S; Grönroos P; Karma P
Lancet; 1980 Sep; 2(8194):547-51. PubMed ID: 6106735
[TBL] [Abstract][Full Text] [Related]
35. Epidemiology of pneumococcal capsular types causing pediatric infections.
Austrian R
Pediatr Infect Dis J; 1989 Jan; 8(1 Suppl):S21-2. PubMed ID: 2648289
[No Abstract] [Full Text] [Related]
36. Serum antibodies to pneumococcal C polysaccharide in children: response to acute pneumococcal otitis media or to vaccination.
Koskela M
Pediatr Infect Dis J; 1987 Jun; 6(6):519-26. PubMed ID: 3615065
[TBL] [Abstract][Full Text] [Related]
37. Polyvalent pneumococcal polysaccharide vaccines; a review of the literature.
Requejo HI
Rev Hosp Clin Fac Med Sao Paulo; 1993; 48(3):130-8. PubMed ID: 8248704
[TBL] [Abstract][Full Text] [Related]
38. Authors' reply to Prymula R. Re: "Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines" [Vaccine 27 (2009) 4739-4740].
Rodgers GL; Arguedas A; Cohen R; Dagan R
Vaccine; 2009 Sep; 27(40):5429-30. PubMed ID: 19643215
[No Abstract] [Full Text] [Related]
39. Serotype distribution of Streptococcus pneumoniae in north-western Greece and implications for a vaccination programme.
Levidiotou S; Vrioni G; Tzanakaki G; Pappa C; Gesouli H; Gartzonika C; Papamichail D; Kremastinou J
FEMS Immunol Med Microbiol; 2006 Nov; 48(2):179-82. PubMed ID: 17064274
[TBL] [Abstract][Full Text] [Related]
40. Vaccination to prevent otitis media in New Zealand.
Walls T; Best E; Murdoch D; Mills N
N Z Med J; 2011 Aug; 124(1340):6-9. PubMed ID: 21952379
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
